Status:
COMPLETED
The Effect of Citrate Dialysate on Clot Formation and Anemia in Hemodialysis Patients
Lead Sponsor:
Bangkok Metropolitan Administration Medical College and Vajira Hospital
Conditions:
Hemodialysis
Citrate
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Acetate-free citrate containing dialysate is expected to be clinically effective in maintaining hemodynamic stability during hemodialysis (HD). It has been demonstrated that citrate dialysate help pro...
Detailed Description
This is the prospective comparison study. This study enrolled chronic hemodialysis patients age more than 18 who undergo hemodialysis 3 times per week for at least 3 months. All the patients should ha...
Eligibility Criteria
Inclusion
- This study enrolled chronic hemodialysis patients age more than 18 who undergo hemodialysis 3 times per week for at least 3 months.
- Serum ferritin 200-1000 ng/L and TSAT of 15-50%.
Exclusion
- age more than 70 years,
- comorbidities influencing citrate metabolism (hepatic failure,liver transplantation,cancer with bone metastasis),
- patients using heparin free protocol,hyperkalemia worsened by hypocalcemia
- contraindication to heparin,
- treatment with cinacalcet, or oral anticoagulant
- patients using central venous catheter with blood flow less than 300 ml/min
- patients using low molecular weight heparin
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03470727
Start Date
September 1 2017
End Date
December 31 2017
Last Update
March 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine ,Vajira hospital,Navamindradhiraj University
Bangkok, Thailand, 10300